Europe's Position on COVID-19 Vaccines Inconsistent with its GMO StanceJanuary 13, 2021
European politicians lauded the breakthroughs in the COVID-19 vaccine, including mRNA vaccines which are developed using genetic engineering. This stance is considered as inconsistent with its position on genetic modification and gene editing which have been prevented to be adopted by farmers in the region except in Spain and Portugal. This is according to Graham Brookes, an agricultural economist with PG Economics UK.
"Robust science-based regulatory frameworks for GMOs have been in place since the 1990s and over 4,300 such science-based regulatory assessments have been conducted in 70 countries by 2019 (ISAAA, 2019). These have facilitated the widespread adoption of GM crops, largely outside Europe," Brookes wrote. He also mentioned that there has been no documented evidence of GM crops' negative impact on human health. Thus, there is a broad consensus among many scientists and regulators worldwide that GM crops are as safe as non-GM counterparts, and they are beneficial to improving food security, reducing the environmental footprint of agriculture, and decreasing global greenhouse gas emissions.
Despite all this evidence, many European politicians continued to use the non-scientific approach in regulating GM technologies, which blocks the access of farmers and consumers to these technologies. Brookes calls for a consistent approach in regulating medicine and agriculture by applying the same rigorous and solely science-based approval approach applied to COVID-19 vaccines to the regulation of GM crops and livestock.
Read more from the original article on the American Farm Bureau Federation website.
You might also like:
- Europe's Current Approach to Food, Agriculture, and the Environment Not Sustainable, say European National Science Academies
- GM Crops' Impact Creates a Halo Effect, Expert Explains
- Long-term Adoption of GM Maize in Spain and Portugal Proves to Benefit Farmers and the Environment
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Study Shows Groups of Bacteria Can Work Together to Protect and Improve Crop Growth
- Viruses Found in Saltwater Microalgae Could Be the Key to Bio-saline Agriculture
- Chinese Scientists Discover Rice Gene for Adaptation to Low Soil Nitrogen
- Europe's Position on COVID-19 Vaccines Inconsistent with its GMO Stance
- International Research Team Identifies Bacterium that Protects Rice Plants from Diseases
- Defra Seeks Support for Gene Editing; Launches Consultation
- Transgenic Chickpeas Exhibit Drought Tolerance, Increased Seed Yield Under Extremely Dry Condition
- CRISPR Offers Glowing Solution to Male Chicks Culling Problem
- Superbug Slaying Antibiotics Increase Production by Tenfold With CRISPR-Cas9
- Expert Proposes Techniques to Address Regulatory Concerns in Gene Editing
- Breakthroughs in Science Using TALENs
- UChicago Creates First Computational Model of Entire COVID-19 Virus
Read the latest:
- Biotech Updates (March 22, 2023)
- Genome Editing Supplement (March 22, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: